Calpain-3 gene expression is decreased during experimental cancer cachexia

Biochimica et Biophysica Acta - General Subjects

Volumn 1475, Issue 1, 2000, Pages 5-9

  Busquets, Sílvia ^a   García Martínez, Cèlia ^a   Alvarez, Belén ^a   Carbó, Neus ^a   López Soriano, Francisco J ^a   Argilés, Josep M ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Calpain 3; Cancer cachexia; m calpain; Proteasome; Protein turnover; Skeletal muscle; Ubiquitin

Indexed keywords

CALPAIN; PROTEASOME; UBIQUITIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASCITES HEPATOMA; CACHEXIA; CANCER; CONTROLLED STUDY; GENE EXPRESSION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN METABOLISM; RAT; REGULATORY MECHANISM; SKELETAL MUSCLE; WEIGHT REDUCTION;

ANIMALS; CACHEXIA; CALPAIN; DNA PROBES; DOWN-REGULATION; GENE EXPRESSION REGULATION, ENZYMOLOGIC; MALE; MUSCLE PROTEINS; MUSCLE, SKELETAL; NEOPLASMS, EXPERIMENTAL; RATS; RATS, WISTAR; RNA;

EID: 0343183054     PISSN: 03044165     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-4165(00)00050-7     Document Type: Article

References (40)

1. Lawson D.H., Richmond A., Nixon D.W., Rudman D. Metabolic approaches to cancer cachexia. Annu. Rev. Nutr. 2:1982;277-301.
2. S.D. Morrison, Cancer cachexia, in: A.L. Liotta (Ed.), Influence of Tumor Development on the Host, Kluwer Academic Publ., 1989, pp. 176-213.
3. Tisdale M.J. Cancer cachexia. Br. J. Cancer. 63:1992;337-342.
4. Kien C.L., Camitta B.M. Increased whole-body protein turnover in children with newly diagnosed leukemia or lymphoma. Cancer Res. 43:1983;5592-5596.
5. Kien C.L., Camitta B.M. Close association of accelerated rates of whole body protein turnover (synthesis and breakdown) and energy expenditure in children with newly diagnosed acute lymphocytic leukaemia. J. Parent. Enteral Nutr. 11:1987;129-134.
6. Beck S.A., Tisdale M.J. Nitrogen excretion in cancer cachexia and its modification by a high fat diet in mice. Cancer Res. 49:1989;3800-3804.
7. Melville S., McNurlan M.A., GrahamCalder A., Garlick P.J. Increased protein turnover despite normal energy metabolism and responses to feeding in patients with lung cancer. Cancer Res. 50:1990;1125-1131.
8. Beck S.A., Smith K.L., Tisdale M.J. Anticachectic and antitumour effect of eicosapentaenoic acid and its effect on protein turnover. Cancer Res. 51:1991;6089-6093.
9. Baccino F.M., Tessitore L., Bonelli G., Isidoro C. Protein turnover states of tumour cells and host tissues in an experimental model. Biomed. Biochim. Acta. 45:1986;1585-1590.
10. Tessitore L., Bonelli G., Isidoro C., Kazakova O.V., Baccino F.M. Comparative studies of protein turnover regulations in tumor cells and host tissues: development and analysis of an experimental model. Toxicol. Pathol. 14:1986;451-456.
11. Tessitore L., Bonelli G., Baccino F.M. Early development of protein metabolic perturbations in the liver and skeletal muscle of tumour-bearing rats. Biochem. J. 241:1987;153-159.
12. Tessitore L., Costelli P., Bonetti G., Baccino F.M. Cancer cachexia, malnutrition, and tissue protein turnover in experimental animals. Arch. Biochem. Biophys. 306:1993;52-58.
13. Llovera M., García-Martínez C., Agell N., Marzábal M., López-Soriano F.J., Argilés J.M. Ubiquitin gene expression is increased in skeletal muscle of tumour-bearing rats. FEBS Lett. 338:1994;311-318.
14. Bhattacharyya J., Thompson K., Sayeed M.N. Calcium-dependent and calcium-independent protease activities in skeletal muscle during sepsis. Circ. Shock. 35:1991;117-122.
15. Huang J., Forsberg N.E. Role of calpain in skeletal muscle protein degradation. Proc. Natl. Acad. Sci. USA. 95:1998;12100-12105.
16. Sorimachi H., Saido T.C., Suzuki K. New era of calpain research. Discovery of tissue-specific calpains. FEBS Lett. 343:1994;1-5.
17. Sorimachi H., Imajoh-Ohmi S., Emori Y., Kawasaki H., Ohno S., Minami Y., Suzuki K. Molecular cloning of a novel mammalian calcium-dependent protease distinct from both m- and μ-types. Specific expression of the mRNA in skeletal muscle. J. Biol. Chem. 264:1989;20106-20111.
18. Kinbara K., Sorimachi H., Ishiura S., Suzuki K. Skeletal muscle-specific calpain p94. Structure and function. Biochem. Pharmacol. 56:1998;415-420.
19. Kinbara K., Ishiura S., Tomioka S., Sorimachi H., Jeong S., Amano S., Kawasaki H., Kolmerer B., Kimura S., Labeit S., Suzuki K. Purification of native p94, a muscle-specific calpain, and characterization of its autolysis. Biochem. J. 335:1998;589-596.
20. Sorimachi H., Kinbara K., Takahashi M., Ishiura S., Sasagawa N., Sorimachi N., Shimada H., Tagawa K., Maruyama K., Suzuki K. Muscle-specific calpain, p94, responsible for limb-girdle muscular distrophy type 2A, associates with connectin through IS2, a p94-specific sequence. J. Biol. Chem. 270:1995;31158-31162.
21. Kinbara K., Sorimachi H., Ishiura S., Suzuki K. Muscle-specific calpain, p94, interacts with the extreme C-terminal region of connectin, a unique region flanked by two immunoglobulin C2 motifs. Arch. Biochem. Biophys. 342:1997;99-107.
22. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate phenol chloroform extraction. Anal. Biochem. 162:1987;156-159.
23. Richard Y., Brous O., Allamand V., Fougerousse F., Chiannilkulchai N., Bourg N., Brenguier L., Devaud C., Pasturaud P., Rodaut C., Hillaire D., Passos-Bueno M., Zatz M., Tishfield J., Fardeau M., Jackson C., Cohen D., Beckmann J.S. Mutations in the proteolytic enzyme calpain-3 cause limb-girdle muscular dystrophy type 2A. Cell. 81:1995;27-40.
24. Bond U., Schlesinger M.J. Ubiquitin is a heat-shock protein in chicken-embryo fibroblasts. Mol. Cell. Biol. 5:1985;949-956.
25. Tanaka K., Kanamaya H., Tamura T., Lee D.H., Kumatori A., Fujiwara T., Ichihara A., Tokunaga F., Aruga R., Iwanaga S. cDNA cloning and sequencing of component C8 of proteasomes from rat hepatoma cells. Biochem. Biophys. Res. Commun. 171:1990;676-683.
26. Moley J.F., Morrison S.D., Gorschboth C.M., Norton J.A. Body composition changes in rats with experimental cancer cachexia: improvement with exogenous insulin. Cancer Res. 48:1988;2784-2787.
27. Popp M.B., Wagner S.C., Enrione E.B., Brito O.J. Host and tumor responses to varying rates of nitrogen infusion in the tumor-bearing rat. Ann. Surg. 207:1988;80-89.
28. Shaw J.H., Wolfe R.R. Whole-body protein kinetics in patients with early and advanced gastrointestinal cancer: the early response to glucose infusion and total parenteral nutrition. Surgery. 103:1988;148-155.
29. Tayek J.A., Istfan N.W., Jones C.T., Hamawy K.J., Bistrian B.R., Blackburn G.L. Influence of the Walker 256 carcinosarcoma on muscle, tumor, and whole-body protein synthesis and growth rate in the cancer-bearing rat. Cancer Res. 46:1986;5649-5654.
30. Tessitore L., Bonelli G., Cecchini G., Amenta J.S., Baccino F.M. Regulation of protein turnover versus growth state: ascites hepatoma as a model for studies both in the animal and in vitro. Arch. Biochem. Biophys. 255:1987;372-384.
31. 2-adrenergic agonist (clenbuterol). J. Clin. Invest. 95:1995;2367-2372.
32. Lowell B.B., Ruderman N.B., Goodman M.N. Evidence that lysosomes are not involved in the degradation of myofibrillar proteins in rat skeletal muscle. Biochem. J. 234:1986;237-240.
33. Tessitore L., Costelli P., Baccino F.M. Pharmacological interference with tissue hypercatabolism in tumour-bearing rats. Biochem. J. 299:1994;71-78.
34. Argilés J.M., López-Soriano F.J. The ubiquitin-dependent proteolytic pathway in skeletal muscle: its role in pathological states. Trends Pharmacol. Sci. 17:1996;223-226.
35. Llovera M., García-Martínez C., Agell N., López-Soriano F.J., Argilés J.M. Muscle wasting associated with cancer cachexia is linked to an important activation of the ATP-dependent ubiquitin-mediated proteolysis. Int. J. Cancer. 61:1995;138-141.
36. Anderson L.V.B., Davison K., Moss J.A., Richard I., Fardeau M., Tomé F.M.S., Hübner C., Lasa A., Colomer J., Beckmann J.S. Characterization of monoclonal antibodies to calpain 3 and protein expression in muscle from patients with limb-girdle muscular distrophy type 2A. Am. J. Physiol. 153:1998;1169-1178.
37. Tsujinaka T., Fujita J., Ebisui C., Yani M., Kominami E., Suzuki K., Tanaka K., Katsume A., Ohsugi Y., Shiozaki H., Monden M. Interleukin 6 receptor antibody inhibits muscle atrophy and modulates proteolytic systems in interleukin 6 transgenic mice. J. Clin. Invest. 97:1996;244-249.
38. Argilés J.M., López-Soriano F.J. The role of cytokines in cancer cachexia. Med. Res. Rev. 19:1999;223-248.
39. Costelli P., Carbó N., Tessitore L., Bagby G.J., López-Soriano F.J., Argilés J.M., Baccino F.M. Tumor necrosis factor-α mediates changes in tissue protein turnover in a rat cancer cachexia model. J. Clin. Invest. 92:1993;2783-2789.
40. Libert C., Brouckaert P., Shaw A., Fiers W. Induction of interleukin-6 by human and murine recombinant interleukin 1 in mice. Eur. J. Immunol. 20:1990;691-694.